Your browser doesn't support javascript.
loading
Unsatisfactory glycemic control in type 2 Diabetes mellitus patients: predictive factors and negative clinical outcomes with the use of antidiabetic drugs
Marczynski, Maria Aparecida; Cortellazzi, Karine Laura; Barberato-Filho, Sílvio; Motta, Rogério Heládio Lopes; Vieira, Alexandre Eduardo Franzin; Quilici, Maria Teresa Verrone; Bergamaschi, Cristiane de Cássia.
Afiliação
  • Marczynski, Maria Aparecida; University of Sorocaba. Department of Pharmaceutical Sciences. Sorocaba. BR
  • Cortellazzi, Karine Laura; State University of Campinas. Dental School of Piracicaba. Department of Social Dentistry. Piracicaba. BR
  • Barberato-Filho, Sílvio; University of Sorocaba. Department of Pharmaceutical Sciences. Sorocaba. BR
  • Motta, Rogério Heládio Lopes; Anesthesiology and Therapeutics Dental School and Research Center. Department of Pharmacology. São Leopoldo Mandic. BR
  • Vieira, Alexandre Eduardo Franzin; Pontifical Catholic University. Sorocaba Medical School. Sorocaba. BR
  • Quilici, Maria Teresa Verrone; Pontifical Catholic University. Sorocaba Medical School. Sorocaba. BR
  • Bergamaschi, Cristiane de Cássia; University of Sorocaba. Department of Pharmaceutical Sciences. Sorocaba. BR
Braz. j. pharm. sci ; 52(4): 801-812, Oct.-Dec. 2016. tab
Article em En | LILACS | ID: biblio-951880
Biblioteca responsável: BR40.1
Localização: BR40.1
ABSTRACT
ABSTRACT Many factors can interfere with glycemic control in patients with type 2 diabetes mellitus and this patient group has an increased risk of experiencing drug-related negative outcomes (DNO). The aim of this study was to identify the predictive factors of unsatisfactory glycemic control and DNO in this group of patients. A cross-sectional study was conducted collecting data from prescriptions and interviews with 100 patients of the Endocrinology Clinic of the Hospital Complex of Sorocaba, São Paulo, Brazil. Variables associated with unsatisfactory glycemic control were determined and the DNO associated with antidiabetic drugs identified. Age (<65 years) (OR=4.09), family history of diabetes (OR=3.24), use of combined therapy to treat diabetes (2-4 antidiabetic drugs) (OR=5.13) and presence of DNO (OR=5.92) were found to be predictive factors for poor patient glycemic control. DNO were observed in 49% of the patients and were caused predominantly by ineffectiveness in patients with poor glycemic control (p<0.05). There was no significant difference between groups (satisfactory and unsatisfactory glycemic control) for DNO caused by safety issues (p>0.05). Characterization of the profile of patients with uncontrolled diabetes and of aspects associated with drug treatment can contribute to the planning of interventions to improve patient care
Assuntos
Palavras-chave

Texto completo: 1 Índice: LILACS Assunto principal: Hipoglicemiantes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Braz. j. pharm. sci Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Índice: LILACS Assunto principal: Hipoglicemiantes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Braz. j. pharm. sci Ano de publicação: 2016 Tipo de documento: Article